Tag Archives: Bevacizumab

Drug Regulation Innovation Patent

Roche Moves Delhi HC to Challenge the Approval Granted by DCGI to Yet Another Biosimilar


A couple of weeks ago, I had analyzed the Delhi High Court’s judgment here and here, delivered by Justice Manmohan Singh, imposing some conditions on the sale of Roche’s breast cancer drug, Trastuzumab (Herceptin), by Biocon and Mylan. While Justice Singh allowed Biocon and Mylan to sell the biosimilar of Trastuzumab subject to some conditions, the decision was appealed to a Division Bench which has allowed the two companies to continue marketing the drug till 21st July. On the heels…


Read More »